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http://dx.doi.org/10.1016/j.ajic.2015.01.013The dofﬁng of personal protective equipment (PPE) after contamination with pathogens such as Ebola
poses a risk to health care workers. Pulsed xenon ultraviolet (PX-UV) disinfection has been used to
disinfect surfaces in hospital settings. This study examined the impact of PX-UV disinfection on an Ebola
surrogate virus on glass carriers and PPE material to examine the potential beneﬁts of using PX-UV to
decontaminate PPE while worn, thereby reducing the pathogen load prior to dofﬁng. Ultraviolet (UV)
safety and coverage tests were also conducted. PX-UV exposure resulted in a signiﬁcant reduction in viral
load on glass carriers and PPE materials. Occupational Safety and Health Administrationedeﬁned UV
exposure limits were not exceeded during PPE disinfection. Predofﬁng disinfection with PX-UV has
potential as an additive measure to the dofﬁng practice guidelines. The PX-UV disinfection should not be
considered sterilization; all PPE should still be considered contaminated and doffed and disposed of
according to established protocols.
Copyright  2015 by the Association for Professionals in Infection Control and Epidemiology, Inc.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Low levels of contamination with Ebola virus are sufﬁcient to contamination of the health care worker’s hands or other part of
infect a human host.1 Personal protective equipment (PPE) protects
health care workers by providing a physical barrier when caring for
infected patients. However, a risk is created during the dofﬁng of
PPE because any error in this detailed process could result in thePH, Xenex Disinfection Ser-
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enses/by-nc-nd/4.0/).their body.2 Despite training and the use of an observer, 100%
proﬁciency to successfully adhering to the Centers for Disease
Control and Prevention’s (CDC’s) guidelines for PPE dofﬁng cannot
be expected at all times.3,4 Fluorescent powder and other tracers
are routinely used during training on the dofﬁng process to
demonstrate the presence of human error despite following these
guidelines.5 Furthermore, health care workers may be asked to don
and doff PPE that they are unfamiliar with or have not received
training on during emergency situations, increasing the likelihood
of a dofﬁng error.
This study examines the use of a pulsed xenon ultraviolet
(PX-UV; Xenex Disinfection Services, San Antonio, TX) germicidal
device as an additional process for disinfecting PPE prior to dofﬁng
as a risk mitigation strategy. The goal of this process is to reduce the
probability of transmission in the event of a dofﬁng error. PX-UV
disinfection has been adopted by multiple hospitals for surface
disinfection6 and has demonstrated a reduction in the infection
rates of Clostridium difﬁcile, methicillin-resistant Staphylococcus
aureus, and other multidrug-resistant organisms.7-9 Ebola virus hasEpidemiology, Inc. Published by Elsevier Inc. This is an open access article under the
Table 1
Effectiveness of PX-UV disinfection on different surfaces inoculated with canine
parvovirus
Inoculated
surface
Distance
(m)
Control (average
log per carrier)
Log reduction (relative to
respective time zero control)
Glass slide 2 5.98 >4.00
Face shield (PPE) 1 5.98 >4.00
Surgical gown (PPE) 1 5.98 >4.00
PPE, personal protective equipment; PX-UV, pulsed xenon ultraviolet.
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more susceptible than hardy spores, such as C difﬁcile.10,11
To determine the feasibility of PPE disinfection using PX-UV, the
authors examined the following in a laboratory setting: (1) the
effectiveness of PX-UV disinfection against an Ebola surrogate virus
on a dry inanimate surface; (2) the effectiveness of PX-UV disin-
fection against PPE material inoculated with an Ebola surrogate
virus; (3) the level of UV exposure for a personwearing PPE; and (4)
the distribution of germicidal light coverage on PPE.
MATERIALS AND METHODS
The CDC and Environmental Protection Agency (EPA) recom-
mend the use of hospital disinfectants with label claims for a
nonenveloped virus (eg, norovirus, rotavirus, adenovirus, polio-
virus) to disinfect environmental surfaces in rooms of patients with
suspected or conﬁrmed Ebola virus infection.12 Canine parvovirus
(ATCC VR-2016), a nonenveloped virus not infective to humans, was
selected as the surrogate organism for this research because it
meets the CDC’s and EPA’s recommendations and was safe to the
researchers involved in this study. The virus was diluted to obtain a
target density of 5-6 log10 per 0.02 ml and was then supplemented
with heat-inactivated fetal bovine serum to a concentration of 5.0%
to simulate typical amounts of protein loading. Glass carriers were
inoculated with 0.02 ml volume in triplicate with triplicate controls
and exposed to PX-UV for 5 minutes at 2 m.
For PPE disinfection, a plastic face shield (T5 hood with
face shield; Stryker, Kalamazoo, MI) and a ﬂuid-resistant gown
(MicroCool gown; Kimberly-Clark, Irving, TX) were used as hard
and soft surface samples. Two and a half centimeters square seg-
ments were cut from the surgical gown and face shield and afﬁxed
onto glass carriers. As described previously, samples were inocu-
lated in triplicatewith triplicate controls with the same volume and
concentration of viral solution. All samples were dried completely,
allowing the solution to soak into the absorbent material of the
gown. Exposure was for 5 minutes at a 1-m distance from the PX-
UV system.
Samples were harvested into a neutralization medium (2% fetal
bovine serum Eagle’s minimal essential medium), serially diluted,
and plated onto host cells (dog tumor cells, ATCC CRL-1542). Plates
were incubated for 6 days, and a secondary hemagglutination assay
was performed to conﬁrm the presence or absence of virus.
To determine the potential UV exposure to a health care
worker through PPE, a spectrometer (USB2000 þ XR; OceanOptics,
Dunedin, FL) was used to determine the amount of UV light that
penetrates the PPE material when it is 1 m away from the UV
source. PPE should be worn according to well-accepted published
protocols, with full coverage of skin and eyes.13 Final readings were
compared with published standards of UV exposure limits recom-
mended for safety purposes.14
UV photochromatic stickers were placed on speciﬁc areas of the
PPE to assess light distribution: clavicle area, shoulders, arms,
chest, back, hips, legs, and shoe covers. The stickers were qualita-
tively assessed for color change to indicate a sufﬁcient dose of
germicidal UV light. The photochromatic stickers were used toassess reﬂectors designed to shorten the exposure time by col-
lecting and redirecting light being emitted from the opposite side of
the disinfection system.
RESULTS
Glass carriers, face shield, and gown material at 5.98 log per
carrier demonstrated a >4.00 log reduction relative to respective
time zero controls. Negative cell culture controls demonstrated no
cytopathic effects (Table 1).
The spectral readings for UV light passing though the face shield
and gowns were less than established UV exposure limits. The
addition of the reﬂector allowed for increased redirection of light
toward the person and effectively reduced the exposure time for
PPE disinfection by half.
DISCUSSION
These results indicate that UV disinfection can be used to reduce
the contamination levels of nonenveloped viruses in a controlled
experimental environment on PPE material. This preliminary safety
and effectiveness data could lead to further research investigating
applications that include real-world PPE contamination of non-
enveloped viruses, especially Ebola. To our knowledge, this is the
ﬁrst studywhere PX-UV disinfection has been shown to be effective
on nonenveloped virus-contaminated PPE material. The distribu-
tion of UV light throughout the PPE, especially when used in
conjunction with the UV reﬂector, provided useful information and
should be a consideration in future research. Photochromic stickers,
if placed prior to UV exposure, may be a method of validation of UV
dose for use in real-world settings.
Prior to conducting experiments where study personnel would
be in the same room with a functioning device, UV exposure
measurements were taken through the PPE material to assure that
personnel were not at risk. The study personnel who wore the PPE
and stood in front of the device reported no adverse symptoms
related to noise of the device or the light from the PX-UV bulb. Heat
stress could be a factor during this process; however, the individual
exposed to the process did not report excessive discomfort. Addi-
tional studies should consider multiple raters of brightness, sound,
and heat factors during the process of PX-UV disinfection.
Whether PX-UV is similarly effective in reducing Ebola virus load
on PPE, the extent towhich bodilyﬂuids obstruct the PX-UVefﬁcacy,
and whether this process leads to a decrease in transmission are
future areas of investigation. Of course, these questions may be
unanswerable because of the extreme rarity of Ebola transmission
in the health care setting in the United States and the justiﬁably
limited access to the Ebola virus for research purposes. Because
the CDC and EPA have recommend hospitals using nonenveloped
virus claims to be adequate markers of effectiveness against Ebola,
we believe this preliminary data could be used by facilities inter-
ested in exploring additional decontamination methods.
It is well-documented that dofﬁng is a risky process with the
potential for causing infection. Hence, adding UV disinfection to the
dofﬁng process has the potential to provide an additional layer of
safety for health care workers based on the data provided here.
However, proper PPE selection, donning practices prior to patient
care, and proper dofﬁng processes are paramount to patient safety
and cannot be compromised. Training on and adherence to estab-
lished practices is the ﬁrst priority for safety.
The addition of PX-UV disinfection does not replace any of the
existing steps associated with dofﬁng PPE, and special care should
be taken with degloving because ﬂuids on gloves may inhibit
PX-UV disinfection. After PX-UV exposure, all PPE should still be
treated as though it is contaminated and doffed and disposed of
C. Jinadatha et al. / American Journal of Infection Control 43 (2015) 412-4414according to the most current CDC protocol. No disinfection system
will be able to completely eliminate the risk associated with dofﬁng
contaminated PPE.
Furthermore, only PX-UV disinfection has been validated in this
study.We did not test low-pressuremercury-based germicidal light
disinfection technology. More research into the uses of the PX-UV
addition into any Ebola containment protocol could provide addi-
tional insight into these preliminary ﬁndings.References
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